Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial.
Saved in:
| Title: | Effect of Hydrolyzed Infant Formula vs Conventional Formula on Risk of Type 1 Diabetes: The TRIGR Randomized Clinical Trial. |
|---|---|
| Authors: | Knip M; University of Helsinki, Helsinki, Finland.; Helsinki University Hospital, Helsinki, Finland., Åkerblom HK; University of Helsinki, Helsinki, Finland., Al Taji E; Charles University, 3rd Faculty of Medicine, Prague, Czech Republic., Becker D; University of Pittsburgh, Pittsburgh, Pennsylvania., Bruining J; Sophia Children's Hospital, Rotterdam, the Netherlands., Castano L; Cruces University Hospital-UPV/EHU-CIBERDEM/CIBERER, Barakaldo, Spain., Danne T; Kinder-und Jugendkrankenhaus Auf Der Bult, Hannover, Germany., de Beaufort C; Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg., Dosch HM; University of Toronto, Toronto, Ontario, Canada., Dupre J; University of Western Ontario, London, Ontario, Canada., Fraser WD; Université de Sherbrooke, Sherbrooke, Quebec, Canada., Howard N; Children's Hospital of Westmead, Sydney, Australia., Ilonen J; University of Turku and Turku University Hospital, Turku, Finland., Konrad D; University Children's Hospital Zürich, Zürich, Switzerland., Kordonouri O; Kinder-und Jugendkrankenhaus Auf Der Bult, Hannover, Germany., Krischer JP; University of South Florida, Tampa., Lawson ML; Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada., Ludvigsson J; Linköping University, Linköping, Sweden., Madacsy L; Semmelweis Medical University, Budapest, Hungary., Mahon JL; University of Western Ontario, London, Ontario, Canada., Ormisson A; Tartu University, Tartu, Estonia., Palmer JP; University of Washington, Seattle., Pozzilli P; University Campus Bio-Medico of Rome, Rome, Italy., Savilahti E; University of Helsinki, Helsinki, Finland., Serrano-Rios M; Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders (CIBERDEM), Madrid, Spain., Songini M; St Michelle Hospital /Azienda Ospedaliera Brotzu-Diabetes Unit, Cagliari, Italy., Taback S; University of Manitoba, Winnipeg, Manitoba, Canada., Vaarala O; University of Helsinki, Helsinki, Finland.; Respiratory, Inflammation and Autoimmunity, Innovative Medicine, AstraZeneca, Gothenburg, Sweden., White NH; Washington University School of Medicine, St Louis, Missouri., Virtanen SM; National Institute of Health and Welfare, Helsinki, Finland., Wasikowa R; Medical University of Wroclaw, Wroclaw, Poland. |
| Corporate Authors: | Writing Group for the TRIGR Study Group |
| Source: | JAMA [JAMA] 2018 Jan 02; Vol. 319 (1), pp. 38-48. |
| Publication Type: | Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2017.19826 |
